RE-LY and RELY-ABLE: Long-term Follow-up of Patients With Non-valvular Atrial Fibrillation Receiving Dabigatran Etexilate for Up to 6.7 Years

被引：0

作者：

Ezekowitz, Michael D. ^{[1
]}

Kent, Anthony P. ^{[2
]}

Pogue, Janice ^{[3
]}

Reilly, Paul A. ^{[4
]}

Brueckmann, Martina ^{[5
]}

Clemens, Andreas ^{[6
]}

Yusuf, Salim ^{[3
]}

Wallentin, Lars ^{[7
]}

Connolly, Stuart J. ^{[3
]}

机构：

[1] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA

[2] Thomas Jefferson Univ, Jefferson Med Coll, Coll Med, Philadelphia, PA 19107 USA

[3] McMaster Univ, Hamilton, ON, Canada

[4] Boehringer Ingelheim Pharmaceut Inc, Clin Dev & Med Affairs, Ridgefield, CT 06877 USA

[5] Boehringer Ingelheim GmbH & Co KG, Cardiol, D-55218 Ingelheim, Germany

[6] Boehringer Ingelheim Pharma GmbH & Co KG, Cardiol, D-55218 Ingelheim, Germany

[7] Univ Uppsala Hosp, Uppsala, Sweden

来源：

关键词：

Dabigatran; Anticoagulation; Atrial fibrillation; Stroke; Intervention;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

10684

引用

页数：2